Safety and Immunogenicity of a rAd35-EnvA Prototype HIV-1 Vaccine in Combination with rAd5-EnvA in Healthy Adults (VRC 012)

BACKGROUND: VRC 012 was a Phase I study of a prototype recombinant adenoviral-vector serotype-35 (rAd35) HIV vaccine, the precursor to two recently published clinical trials, HVTN 077 and 083. On the basis of prior evaluation of multiclade rAd5 HIV vaccines, Envelope A (EnvA) was selected as the sta...

Descripción completa

Detalles Bibliográficos
Autores principales: Crank, Michelle C., Wilson, Eleanor M. P., Novik, Laura, Enama, Mary E., Hendel, Cynthia S., Gu, Wenjuan, Nason, Martha C., Bailer, Robert T., Nabel, Gary J., McDermott, Adrian B., Mascola, John R., Koup, Richard A., Ledgerwood, Julie E., Graham, Barney S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112788/
https://www.ncbi.nlm.nih.gov/pubmed/27846256
http://dx.doi.org/10.1371/journal.pone.0166393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112788/
https://www.ncbi.nlm.nih.gov/pubmed/27846256
http://dx.doi.org/10.1371/journal.pone.0166393

Ejemplares similares